Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

104 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Impact of 3-year lifestyle intervention on postprandial glucose metabolism: the SLIM study.
Roumen C, Corpeleijn E, Feskens EJ, Mensink M, Saris WH, Blaak EE. Roumen C, et al. Diabet Med. 2008 May;25(5):597-605. doi: 10.1111/j.1464-5491.2008.02417.x. Diabet Med. 2008. PMID: 18445174 Clinical Trial.
Effect of training intensity on insulin sensitivity as evaluated by insulin tolerance test.
Borghouts LB, Backx K, Mensink MF, Keizer HA. Borghouts LB, et al. Eur J Appl Physiol Occup Physiol. 1999 Oct;80(5):461-6. doi: 10.1007/s004210050618. Eur J Appl Physiol Occup Physiol. 1999. PMID: 10502080
Improved skeletal muscle oxidative enzyme activity and restoration of PGC-1 alpha and PPAR beta/delta gene expression upon rosiglitazone treatment in obese patients with type 2 diabetes mellitus.
Mensink M, Hesselink MK, Russell AP, Schaart G, Sels JP, Schrauwen P. Mensink M, et al. Int J Obes (Lond). 2007 Aug;31(8):1302-10. doi: 10.1038/sj.ijo.0803567. Epub 2007 Feb 20. Int J Obes (Lond). 2007. PMID: 17310221 Clinical Trial.
Peroxisome proliferator-activated receptor-gamma coactivator-1 and insulin resistance: acute effect of fatty acids.
Hoeks J, Hesselink MK, Russell AP, Mensink M, Saris WH, Mensink RP, Schrauwen P. Hoeks J, et al. Diabetologia. 2006 Oct;49(10):2419-26. doi: 10.1007/s00125-006-0369-2. Epub 2006 Aug 1. Diabetologia. 2006. PMID: 16896940
Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects.
Schrauwen-Hinderling VB, Kooi ME, Hesselink MK, Jeneson JA, Backes WH, van Echteld CJ, van Engelshoven JM, Mensink M, Schrauwen P. Schrauwen-Hinderling VB, et al. Diabetologia. 2007 Jan;50(1):113-20. doi: 10.1007/s00125-006-0475-1. Epub 2006 Nov 9. Diabetologia. 2007. PMID: 17093944
METHODS: In 12 overweight type 2 diabetes patients and nine controls with similar BMI (29.4 +/- 1 and 29.3 +/- 0.9 kg/m(2) respectively) in vivo mitochondrial function was determined by measuring phosphocreatine recovery half-time (PCr half-time) immediately after exercise …
METHODS: In 12 overweight type 2 diabetes patients and nine controls with similar BMI (29.4 +/- 1 and 29.3 +/- 0.9 kg/m(2) respective …
Predictors of lifestyle intervention outcome and dropout: the SLIM study.
Roumen C, Feskens EJ, Corpeleijn E, Mensink M, Saris WH, Blaak EE. Roumen C, et al. Eur J Clin Nutr. 2011 Oct;65(10):1141-7. doi: 10.1038/ejcn.2011.74. Epub 2011 May 18. Eur J Clin Nutr. 2011. PMID: 21587283 Clinical Trial.
Insulin acutely upregulates protein expression of the fatty acid transporter CD36 in human skeletal muscle in vivo.
Corpeleijn E, Pelsers MM, Soenen S, Mensink M, Bouwman FG, Kooi ME, Saris WH, Glatz JF, Blaak EE. Corpeleijn E, et al. J Physiol Pharmacol. 2008 Mar;59(1):77-83. J Physiol Pharmacol. 2008. PMID: 18441389 Clinical Trial.
We investigated differences in fatty acid transporter content before and at the end of a hyperinsulinemic euglycemic clamp in skeletal muscle (m. vastus lateralis) of obese, glucose-intolerant men (IGT) and obese normal glucose tolerant controls (NGT). ...
We investigated differences in fatty acid transporter content before and at the end of a hyperinsulinemic euglycemic clamp in skeletal muscl …
Skeletal muscle uncoupling protein-3 restores upon intervention in the prediabetic and diabetic state: implications for diabetes pathogenesis?
Mensink M, Hesselink MK, Borghouts LB, Keizer H, Moonen-Kornips E, Schaart G, Blaak EE, Schrauwen P. Mensink M, et al. Diabetes Obes Metab. 2007 Jul;9(4):594-6. doi: 10.1111/j.1463-1326.2006.00628.x. Diabetes Obes Metab. 2007. PMID: 17587402
Improvements in glucose tolerance and insulin sensitivity after lifestyle intervention are related to changes in serum fatty acid profile and desaturase activities: the SLIM study.
Corpeleijn E, Feskens EJ, Jansen EH, Mensink M, Saris WH, de Bruin TW, Blaak EE. Corpeleijn E, et al. Diabetologia. 2006 Oct;49(10):2392-401. doi: 10.1007/s00125-006-0383-4. Epub 2006 Aug 3. Diabetologia. 2006. PMID: 16896932 Clinical Trial.
Lifestyle changes and lipid metabolism gene expression and protein content in skeletal muscle of subjects with impaired glucose tolerance.
Mensink M, Blaak EE, Vidal H, De Bruin TW, Glatz JF, Saris WH. Mensink M, et al. Diabetologia. 2003 Aug;46(8):1082-9. doi: 10.1007/s00125-003-1152-2. Epub 2003 Jul 11. Diabetologia. 2003. PMID: 12856127
104 results
Jump to page
Feedback